The Kent and Medway Integrated Care Board (ICB) DOES NOT currently support or fund the use of tirzepatide (Mounjaro) or semaglutide (Ozempic, Wegovy) injections for weight loss in non-diabetic patients. As a result, the GP practice cannot prescribe these medications for weight loss in non-diabetic patients. There is also a criteria for diabetics patients such as as BMI of over 35 and the patient must have tried 3 other diabetic medications previously. The practice will review this situation if ICB guidance changes. For weight loss advice, patients are encouraged to consider local weight loss services available at One You Kent www.kentcht.nhs.uk/service/one-you-kent/one-you-weight-loss/